The University of Chicago Header Logo

Connection

Harvey M. Golomb to Maximum Tolerated Dose

Back to Details
This is a "connection" page, showing publications Harvey M. Golomb has written about Maximum Tolerated Dose.
Harvey M. Golomb
Connection Strength
0.007
Maximum Tolerated Dose
  1. A phase I-phase II study of vinorelbine with cisplatin, 5-fluorouracil, and leucovorin for advanced non-small cell lung cancer. Cancer J Sci Am. 1995 Nov-Dec; 1(4):288-94.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.